A single blind, randomized, comparative clinical trial evaluating the effectiveness of homoeopathic remedies Belladona 6C versus Euphrasia 6C in the management of screen induced Asthenopia

Asthenopia commonly referred to as digital eye strain or computer vision syndrome is an increasingly prevalent condition associated with prolonged use of digital devices It manifests as visual discomfort headaches blurred vision dry eyes and reduced visual efficiency significantly affecting quality of life and occupational productivity Conventional management primarily involves ergonomic measures and optical corrections which provide only temporary relief Homoeopathy with its individualized and holistic approach offers potential as a safe and effective complementary treatment This single blind randomized comparative clinical trial is designed to evaluate the effectiveness of two homoeopathic remedies Belladonna 6C versus Euphrasia 6C in the management of screen induced asthenopia A total of 30 participants aged 18 to 40 years meeting inclusion criteria with Computer Vision Syndrome Questionnaire CVS Q scores more than or equal to 6 will be randomized into two groups Group A receiving Belladonna 6C and Group B receiving Euphrasia 6C each administered once weekly for three months along with daily placebo All participants will also receive standardized ergonomic advice for digital device usage Outcome assessment will be based on changes in CVS Q scores recorded at baseline and during follow ups every 15 days The primary objective is to compare the reduction in subjective symptoms between the two groups Secondary objectives include evaluating improvements in visual comfort performance during screen related tasks and the duration of sustained improvement The study seeks to provide clinical evidence regarding the comparative effectiveness of Belladonna 6C and Euphrasia 6C in screen induced asthenopia aiming to contribute to the development of a specific therapeutic protocol in homoeopathic practice for managing digital eye strain